Artificial Intelligence Drives Industry Response to Project Optimus - Applied Clinical Trials

Retrieved on: 2024-02-27 19:31:31

Tags for this article:

Clinical research

Design of experiments

Patient-reported outcome

Trastuzumab

Personalized medicine

COVID-19 drug development

Click the tags to see associated articles and topics

Artificial Intelligence Drives Industry Response to Project Optimus - Applied Clinical Trials. View article details on HISWAI: https://www.appliedclinicaltrialsonline.com/view/artificial-intelligence-drives-industry-response-to-project-optimus

Summary

The article discusses the FDA's draft guidance under Project Optimus, highlighting the shift in oncology drug development towards patient-centric approaches and the use of AI, like ChatGPT, to improve the efficiency of clinical trials for biopharmaceuticals, including targeted therapies like trastuzumab.

Article found on: www.appliedclinicaltrialsonline.com

View Original Article